Triumph Capital Management Sana Biotechnology, Inc. Transaction History

Triumph Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$2.83 - $5.14 $38,700 - $70,289	-13,675 Reduced 93.19%	1,000 $3,000
Q2 2025 Dec 23, 2025	BUY	$1.34 - $2.97 $19,664 - $43,584	14,675 New	14,675 $40,000
Q2 2025 Jul 09, 2025	SELL	$1.34 - $2.97 $9,380 - $20,790	-7,000 Reduced 32.3%	14,675 $40,000
Q1 2025 May 06, 2025	BUY	$1.65 - $4.3 $35,763 - $93,202	21,675 New	21,675 $36,000

196

121M

194K

353K

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $759M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Triumph Capital Management, based on Form 13F filings with the SEC.

Stay updated on Triumph Capital Management with notifications on news.